1)Food and Drug Administration, et al ; Centers for Disease Control and Prevention(CDC) : Revised device labeling for the Cepheid Xpert MTB/RIF assay for detecting Mycobacterium tuberculosis. MMWR Morb Mortal Wkly Rep 64(7) : 193, 2015. PMID 25719683
2)Cowan JF, et al:Clinical impact and cost-effectiveness of Xpert MTB/RIF testing in hospitalized patients with presumptive pulmonary tuberculosis in the United States. Clin Infect Dis 64(4) : 482-489, 2017. PMID 28172666
3)Luetkemeyer AF, et al : Evaluation of Xpert MTB/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings. Clin Infect Dis 62(9) : 1081-1088, 2016. PMID 26839383
4)Chaisson LH, et al : Association of rapid molecular testing with duration of respiratory isolation for patients with possible tuberculosis in a US hospital. JAMA Intern Med 178(10) : 1380-1388, 2018. PMID 30178007
5)Chaisson LH, et al : Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis ; a hypothetical trial. Clin Infect Dis 59(10) : 1353-1360, 2014. PMID 25091300
6)Lippincott CK, et al : Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States. Clin Infect Dis 59(2) : 186-192, 2014. PMID 24729506
7)Campos M, et al : Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am J Respir Crit Care Med 178(3) : 300-305, 2008. PMID 18467509
8)Andreas Fløe, et al : Shortening isolation of patients with suspected tuberculosis by using polymerase chain reaction analysis ; a nationwide cross-sectional study. Clin Infect Dis 61(9) : 1365-1373, 2015. PMID 26175524